News

Filter by Category

All Blog Events Newsletters Podcasts Posters Publications Webinars Workshops

Filter by Program

Filter by Publish Date

July 16, 2025

C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....

July 9, 2025

C-Path’s Kristen Swingle Named a “Woman Leading the Region” by BizTucson

C-Path) is proud to announce that President and Chief Operating Officer Kristen Swingle, M.S., has been named a 2025 BizTucson..

July 9, 2025

Celebrating 20 Years of Impact: C-Path Featured in Special BizTucson Anniversary Issue

This year, C-Path proudly marks 20 years of advancing regulatory science and reshaping how new treatments are developed...

June 20, 2025

C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury

C-Path, through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain...

June 20, 2025

C-Path’s T1D Consortium to Release a Clinical Trial Simulation Tool for New-Onset Trial Design

C-Path's Type 1 Diabetes Consortium today announced the release of a pilot version of their regulatory-grade new-onset clinical...

June 18, 2025

C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes

C-Path's Translational Therapeutics Accelerator (TRxA) proudly announced a $250,000 grant...

May 29, 2025

Critical Path Institute and Citizen Health Partner to Accelerate Drug Development for Neuromuscular Disorders

C-Path, a global nonprofit accelerating drug development through data science and regulatory...

May 27, 2025

C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium

C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is

May 20, 2025

The Critical Path Institute Podcast: eCOA Conversations with Florence Mowlem, Karl McEvoy, and Brian Lillis

Welcome to the latest Critical Path Institute Podcast episode—the first in the eCOA Conversations series.

May 12, 2025

C-Path’s Translational Therapeutics Accelerator Awards $815,000 Grant for Drug Development Project in Advanced Prostate Cancer

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today an $815,000 ($1,250,000 AUD) grant to Brian Dymock.

Previous23 4...31 Next